Answers are grounded in this paper and cite their sources.
A post-hoc analysis examines thyroid function's role in survival among nasopharyngeal carcinoma patients treated with KL-A167, suggesting its use as a biomarker.
Elevated basal TSH levels are independently associated with improved survival in R/M NPC patients receiving KL-A167. Baseline TSH may serve as a simple, non-invasive biomarker for risk stratification and personalizing immunotherapy in this population.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: